emjreviews.com
Cure8 news brief
Faecal Calprotectin Predicts Inflammation in Crohn’s Disease
Tests and monitoring
Biomarkers
Fecal calprotectin
Imaging
Ileostomy
Clinical study
Adult patients
Patients On Biologics
Why This Matters
Faecal calprotectin from ileostomy output could provide a non-invasive way to detect small-bowel inflammation after surgery, helping to guide monitoring and reduce reliance on invasive tests for postoperative Crohn’s patients.
Who Should Pay Attention
Post-surgery Crohn’s patients with an ileostomy, clinicians who manage postoperative IBD care, researchers studying biomarkers for Crohn’s disease, and caregivers involved in monitoring recovery.
Study Snapshot
Story typeResearch news
Evidence typeClinical study
Source depthFull source text
What To Know
A team analysed 224 FC tests from 101 Crohn’s disease patients with an ileostomy and compared results to imaging and endoscopy. Median FC values were substantially higher when inflammation was present; the authors proposed cutoff values for POCT and ELISA that yielded high AUCs (around 0.89–0.90).
The study reports no significant difference between POCT and ELISA performance, suggesting either method might be useful in clinical monitoring from ileostomy output. Practical point For patients and clinicians, this study suggests a non-invasive way to monitor small-bowel inflammation after ileostomy that could reduce need for more invasive tests.
However, the findings come from a single retrospective cohort and should be considered alongside clinical context and local testing availability.
Keep In Mind
This is a retrospective, single-cohort study; proposed cutoff values and diagnostic accuracy should be validated prospectively and in other centers before changing standard practice. The original research article (BMC Gastroenterology) is cited for full methods and detailed results.
Source Details
Review the original publication for the complete reporting, methods, and context.
Clinical study
Article type assigned from Cure8 classification; confirm details in the original source.
Publicationemjreviews.com
Indexed viaBing News
Source typeResearch news
PublishedFeb 18, 2025, 2:00 AM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Monitoring Crohn's Disease After Surgery with Fecal Calprotectin - Physician's Weekly
People with Crohn's disease who have an ileostomy need reliable, noninvasive tools to monitor for postoperative small-bowel inflammation. This study suggests fecal calprotectin measured from ileostomy output may help...
Fecal calprotectin from ileostomy output in patients with Crohn's disease | BMC Gastroenterology
People with Crohn’s disease who have an ileostomy have limited noninvasive ways to monitor small-bowel inflammation. This study suggests measuring fecal calprotectin from ileostomy output could help detect postoperative...
Dual Testing Strategy Linked to Long-Term Benefits in Crohn's Disease - Medscape
This study suggests using both faecal calprotectin and intestinal ultrasound together can better identify patients who reach deeper, transmural healing — and those patients had lower risk of bowel-damage progression....